Strahlentherapie und Onkologie

Interstitial brachytherapy for eyelid carcinoma

M. Krengli, L. Masini, A.M. Comoli, E. Negri, L. Deantonio, A. Filomeno, G. Gambaro

Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer

V. Budach, E.-T. Becker, D. Boehmer, H. Badakhshi, U. Jahn, K.-D. Wernecke, C. Stromberger

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck

P. Balermpas, C. Bauer, I. Fraunholz, A. Ottinger, J. Wagenblast, T. Stöver, O. Seitz, E. Fokas, C. Rödel, C. Weiss

Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer

R. Bütof, K. Kirchner, S. Appold, S. Löck, A. Rolle, G. Höffken, M. Krause, M. Baumann

Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer

B. van Oorschot, B. Assenbrunner, M. Schuler, G. Beckmann, M. Flentje

A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer

C. Ostheimer, M. Bache, A. Güttler, M. Kotzsch, D. Vordermark

Breast cancer patients with metastatic spinal cord compression

A. Weber, T. Bartscht, J.H. Karstens, S.E. Schild, D. Rades

Time evaluation of image-guided radiotherapy in patients with spinal bone metastases

H. Rief, D. Habermehl, K. Schubert, J. Debus, S.E. Combs

The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome

O.J. Ott, S. Hertel, U.S. Gaipl, B. Frey, M. Schmidt, R. Fietkau

Re-irradiation for painful heel spur syndrome

M.G. Hautmann, U. Neumaier, O. Kölbl

Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy

E.-M. Thurner, S. Krenn-Pilko, U. Langsenlehner, W. Renner, A. Gerger, K.S. Kapp, T. Langsenlehner

Target volume coverage and dose to organs at risk in prostate cancer patients

P. Hüttenrauch, M. Witt, D. Wolff, S. Bosold, R. Engenhart-Cabillic, J. Sparenberg, H. Vorwerk, K. Zink

Neoadjuvante Kurzzeitbestrahlung mit anschließender Chemotherapie oder simultane Radiochemotherapie bei lokal nicht sicher kurativ resektablen Rektumkarzinomen

G. Klautke, R. Sauer

Gemcitabin- oder Capecitabin-basierte Radiochemotherapie beim lokal fortgeschrittenen Pankreaskarzinom (SCALOP)

S.B. Harrabi, M.W. Büchler, J. Werner, S.E. Combs

Erratum to: Androgen receptor expression

D. Rades, N.D. Seibold, S.E. Schild, K.L. Bruchhage, M.P. Gebhard, F. Noack

Erratum to: Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck

D. Rades, N.D. Seibold, A. Hoffmann, M.P. Gebhard, F. Noack, C. Thorns, S.E. Schild

Erratum to: Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck

D. Rades, N.D. Seibold, M.P. Gebhard, F. Noack, K.L. Bruchhage, S.E. Schild

Erratum to: Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck

N.D. Seibold, S.E. Schild, K.L. Bruchhage, M.P. Gebhard, F. Noack, D. Rades

Erratum to: Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck

N.D. Seibold, S.E. Schild, M.P. Gebhard, F. Noack, U. Schröder, D. Rades

Mitteilungen der Fachgesellschaften